Screener
Denali Therapeutics Inc. DNLI Business Segments — Total collaboration revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Denali Therapeutics Inc.’s 10-K, filed February 26, 2026.
- Filed
- Feb 26, 2026, 4:11 PM EST
- Fiscal year
- FY2025
- Accession
- 0001714899-26-000021
| Line item | Year Ended December 31, 2025 | Year Ended December 31, 2024 | Year Ended December 31, 2023 |
|---|---|---|---|
| Collaboration revenue: | |||
| Collaboration revenue from customers(1) | — | — | $330,531 |
| Total collaboration revenue | — | — | 330,531 |
| Operating expenses: | |||
| Research and development(2) | 418,778 | 396,440 | 423,876 |
| General and administration | 136,564 | 105,438 | 103,354 |
| Total operating expenses | 555,342 | 501,878 | 527,230 |
| Gain from divestiture of small molecule programs | — | 14,537 | — |
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is Denali Therapeutics Inc.'s business segments — total collaboration revenue?
- Denali Therapeutics Inc. (DNLI) reported business segments — total collaboration revenue of $0 in Q4 2025.
- What is the long-term trend for Denali Therapeutics Inc.'s business segments — total collaboration revenue?
- Over 3 years (2022 to 2025), Denali Therapeutics Inc.'s business segments — total collaboration revenue has grown at a -100.0% compound annual growth rate (CAGR), from $108.46M to $0.
- What does business segments — total collaboration revenue mean?
- This metric captures the total revenue recognized from strategic partnerships, licensing agreements, and collaborative research arrangements within the therapeutics segment. It reflects the company's ability to monetize its intellectual property and research pipeline through external industry alliances. Fluctuations in this metric often indicate the timing of milestone achievements or the initiation of new joint development programs.
Ask your AI about Denali Therapeutics Inc.'s business segments — total collaboration revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude